home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

From Detection to Decisions: Biomarkers in Neurodegenerative Disease

 
  October 06, 2026  
     
 


Xtalks — The Life Science Community™, Online webinar
2026-11-10


For neurodegenerative disease clinical trials, understanding how a condition is progressing and whether a treatment is having an effect can be difficult using traditional assessments alone. Biomarker science, digital health technologies and precision medicine are creating new ways to capture objective measures of disease. As the prevalence of neurodegenerative conditions continues to grow, there is an increasing need for innovative tools to detect disease, strengthen clinical trial design and support the development of new therapies. This webinar explores how emerging biomarker strategies can help address these challenges across clinical research and therapeutic development.

Biological and imaging biomarkers, together with digital and wearable technologies, are enabling researchers to detect disease earlier, characterize patient populations more accurately, track disease progression and assess treatment response with greater precision. These objective, actionable measures can help inform decision-making across the drug development process.

The featured panelists will examine how biological, digital and wearable markers are being applied across neurodegenerative disease research. Attendees will learn how these approaches can support more efficient clinical trials, strengthen patient selection, enable more personalized treatment strategies and contribute to the development of next-generation therapies.

The session will also examine real-world applications, practical implementation considerations and emerging trends influencing the future of CNS research. Attendees will gain insight into both the opportunities and challenges of incorporating innovative biomarker strategies into research programs and clinical development initiatives. As neurodegenerative disease research becomes increasingly precise, data-driven and patient-centered, biomarkers and digital technologies will play an important role in advancing new treatments and improving patient outcomes.

Register for this webinar to learn how biomarker strategies can advance neurodegenerative disease research and support more precise, data-driven clinical trials.

 
 
Organized by: Xtalks — The Life Science Community™
Invited Speakers:

Bob Dagher, Chief Medical Officer, Clinilabs

Nicklas Linz, CEO and Co-Founder, Ki:elements

Chiara Capra, Co-Founder & CEO, LIFE Neurotech & CPO, Sense4Care

 
Deadline for Abstracts: 2026-11-10
 
Registration:

https://xtalks.com/webinars/from-detection-to-decisions-biomarkers-in-neurodegenerative-disease/

E-mail: clientservices@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.